hydroxyproline has been researched along with Insulin Resistance in 7 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Excerpt | Relevance | Reference |
---|---|---|
"In boys, the BCAA score corresponded with decreasing C-peptide, C-peptide-based insulin resistance (CP-IR), total cholesterol (TC), and low-density-lipoprotein cholesterol (LDL)." | 3.91 | Metabolomic profiles and development of metabolic risk during the pubertal transition: a prospective study in the ELEMENT Project. ( Cantoral, A; Perng, W; Peterson, KE; Song, PXK; Tang, L; Tellez-Rojo, MM, 2019) |
" Fourth, hydroxyproline concentration decreased in the left ventricle and hypertension was normalised." | 3.88 | Dietary soya protein improves intra-myocardial lipid deposition and altered glucose metabolism in a hypertensive, dyslipidaemic, insulin-resistant rat model. ( Chicco, A; Creus, A; Ferreira, MR; Lombardo, YB; Oliva, ME, 2018) |
" Glucose infusion rates (index of insulin resistance, insulin resistance), heart weight, the heart weight to body weight ratio, myocardial apoptotic index, cardiac hydroxyproline content, and cardiac tissue collagen type I and collagen type 3 content were measured." | 3.76 | Insulin resistance and heart injury in rats with insulin resistance or type 2 diabetes mellitus. ( Peng, XD; Yang, ZH, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Oliva, ME | 1 |
Creus, A | 1 |
Ferreira, MR | 1 |
Chicco, A | 1 |
Lombardo, YB | 1 |
Kenéz, Á | 1 |
Warnken, T | 1 |
Feige, K | 1 |
Huber, K | 1 |
Alba, DL | 1 |
Farooq, JA | 1 |
Lin, MYC | 1 |
Schafer, AL | 1 |
Shepherd, J | 1 |
Koliwad, SK | 1 |
Perng, W | 1 |
Tang, L | 1 |
Song, PXK | 1 |
Tellez-Rojo, MM | 1 |
Cantoral, A | 1 |
Peterson, KE | 1 |
Yang, ZH | 2 |
Peng, XD | 2 |
Berria, R | 1 |
Wang, L | 1 |
Richardson, DK | 1 |
Finlayson, J | 1 |
Belfort, R | 1 |
Pratipanawatr, T | 1 |
De Filippis, EA | 1 |
Kashyap, S | 1 |
Mandarino, LJ | 1 |
7 other studies available for hydroxyproline and Insulin Resistance
Article | Year |
---|---|
Dietary soya protein improves intra-myocardial lipid deposition and altered glucose metabolism in a hypertensive, dyslipidaemic, insulin-resistant rat model.
Topics: Animals; Carnitine O-Palmitoyltransferase; Dietary Proteins; Dietary Sucrose; Disease Models, Animal | 2018 |
Lower plasma trans-4-hydroxyproline and methionine sulfoxide levels are associated with insulin dysregulation in horses.
Topics: Animals; Blood Glucose; Glucose Tolerance Test; Horses; Hydroxyproline; Insulin; Insulin Resistance; | 2018 |
Subcutaneous Fat Fibrosis Links Obesity to Insulin Resistance in Chinese Americans.
Topics: Adiposity; Adult; Aged; Anthropometry; Asian; Blood Glucose; Body Composition; Body Mass Index; Fema | 2018 |
Metabolomic profiles and development of metabolic risk during the pubertal transition: a prospective study in the ELEMENT Project.
Topics: Acetylcarnitine; Adolescent; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Asparagine; Biomark | 2019 |
Insulin resistance and heart injury in rats with insulin resistance or type 2 diabetes mellitus.
Topics: Analysis of Variance; Animals; Apoptosis; Blood Glucose; Body Weight; Collagen; Diabetes Mellitus, E | 2010 |
Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Collagen Type I; Collagen Type III; Dia | 2010 |
Increased collagen content in insulin-resistant skeletal muscle.
Topics: Adult; Biopsy; Collagen Type I; Collagen Type III; Diabetes Mellitus, Type 2; Extracellular Matrix; | 2006 |